These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9668249)

  • 1. Acetylcholine receptor epitopes in ocular myasthenia.
    Kaminski HJ
    Ann N Y Acad Sci; 1998 May; 841():309-19. PubMed ID: 9668249
    [No Abstract]   [Full Text] [Related]  

  • 2. Why are eye muscles frequently involved in myasthenia gravis?
    Kaminski HJ; Maas E; Spiegel P; Ruff RL
    Neurology; 1990 Nov; 40(11):1663-9. PubMed ID: 1700335
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum acetylcholine receptor antibody measurement in myasthenia gravis. Some trials to background radioactivity in radioimmunoassay.
    Buot WL; Goto I; Oda K; Kuroiwa Y
    J Neurol Sci; 1982; 57(1):111-20. PubMed ID: 6185642
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy.
    Weinreb H; Klein J; Kupersmith M
    N Y State J Med; 1986 Aug; 86(8):439-42. PubMed ID: 3463893
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respective role of thymus and muscle in autoimmune myasthenia gravis.
    Moulian N; Wakkach A; Guyon T; Poëa S; Aïssaoui A; Levasseur P; Cohen-Kaminsky S; Berrih-Aknin S
    Ann N Y Acad Sci; 1998 May; 841():397-406. PubMed ID: 9668265
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular presentation of myasthenia gravis: A natural history cohort.
    Kamarajah SK; Sadalage G; Palmer J; Carley H; Maddison P; Sivaguru A
    Muscle Nerve; 2018 Apr; 57(4):622-627. PubMed ID: 28881457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):383-7. PubMed ID: 6101172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 10. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis.
    Agius MA; Yuen E
    Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of humoral immunity in myasthenia gravis.
    Zurn AD; Fulpius BW
    Prog Brain Res; 1979; 49():435-40. PubMed ID: 229518
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis: antibodies to extracellularly exposed antigenic determinants of acetylcholine receptor.
    Oda K; Shibasaki H
    Neurology; 1986 Oct; 36(10):1374-7. PubMed ID: 2429233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal administration of synthetic acetylcholine receptor T epitopes affects the immune response to the acetylcholine receptor and prevents experimental myasthenia gravis.
    Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():560-4. PubMed ID: 9668295
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
    Lindstrom J
    Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.